Tramadol study exposes misconceptions about prescription opioid risks
Substance useMeanwhile, a record-breaking naloxone training fueled debate about teens and overdose prevention....
Explore discourse on substance use, including general references to drugs, specific substances such as opioids and stimulants, and topics like harm reduction and naloxone. Use our real-time dashboards below for the most up-to-date information in your area. Insights are updated by Monday of each week.
Jump to dashboardsMost recent
Meanwhile, a record-breaking naloxone training fueled debate about teens and overdose prevention....
Social media users also repeated fentanyl exposure myths and questioned naloxone’s effectiveness....
Debate around overdose prevention tools continued after the unveiling of a vending machine in Ohio....
A new bill to expand access to naloxone and SUD services received both celebration and stigma....
Others spread false claims about SSPs and advocated for non-opioid pain medications....
Social media users also responded to a new ad campaign aiming to prevent fentanyl deaths....
Plus, conversations about kratom continued....
Meanwhile, Florida’s emergency ban on a kratom byproduct sparked debate....
Free naloxone continues to draw criticism and false claims that it “encourages” drug use....
Plus, posts discussed kratom products and “flysky,” an emerging illicit substance causing concern in Pittsburgh....
Dashboards
Click here to explore the latest data at the national and regional level.
Looking for support with your own infodemiology work, or want to partner to advance the field? Complete the form below or contact our team at info@infodemiology.com.